AstraZeneca to buy cell therapy startup EsoBiotec for $425M upfront
AstraZeneca said Monday that it has agreed to acquire a cell therapy biotech founded just four years ago for an upfront payment of $425 million. The UK pharma has also promised up to $575 million ...
AstraZeneca said Monday that it has agreed to acquire a cell therapy biotech founded just four years ago for an upfront payment of $425 million. The UK pharma has also promised up to $575 million ...
